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Abstract
Background: Smoking during pregnancy (SDP) and the postpartum period has serious health outcomes for the
mother and infant. Although some systematic reviews have shown the impact of maternal SDP on particular
conditions, a systematic review examining the overall health outcomes has not been published. Hence, this paper
aimed to conduct an umbrella review on this issue.
Methods: A systematic review of systematic reviews (umbrella review) was conducted according to a protocol
submitted to PROSPERO (CRD42018086350). CINAHL, EMBASE, MEDLINE, PsycINFO, Web of Science, CRD Database
and HMIC databases were searched to include all studies published in English by 31 December 2017, except those
focusing exclusively on low-income countries. Two researchers conducted the study selection and quality
assessment independently.
Results: The review included 64 studies analysing the relationship between maternal SDP and 46 health conditions.
The highest increase in risks was found for sudden infant death syndrome, asthma, stillbirth, low birth weight and
obesity amongst infants. The impact of SDP was associated with the number of cigarettes consumed. According to
the causal link analysis, five mother-related and ten infant-related conditions had a causal link with SDP. In addition,
some studies reported protective impacts of SDP on pre-eclampsia, hyperemesis gravidarum and skin defects on
infants. The review identified important gaps in the literature regarding the dose-response association, exposure
window, postnatal smoking.
Conclusions: The review shows that maternal SDP is not only associated with short-term health conditions (e.g.
preterm birth, oral clefts) but also some which can have life-long detrimental impacts (e.g. obesity, intellectual
impairment).
Implications: This umbrella review provides a comprehensive analysis of the overall health impacts of SDP. The
study findings indicate that while estimating health and cost outcomes of SDP, long-term health impacts should be
considered as well as short-term effects since studies not including the long-term outcomes would underestimate
the magnitude of the issue. Also, interventions for pregnant women who smoke should consider the impact of
reducing smoking due to health benefits on mothers and infants, and not solely cessation.
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Background
Smoking during pregnancy (SDP) is a significant public
health concern due to adverse health outcomes on
mothers and infants, such as miscarriage, low birth
weight (LBW), preterm birth, and asthma [1–4]. The
prevalence of SDP is around 10% in high-income coun-
tries (HICs) [5–7] and 3% in low- and middle-income
countries (LMICs) [8].
Smoking during pregnancy generates a considerable
cost burden and the annual cost of smoking-related
pregnancy complications has been estimated to be be-
tween £8 and £64 million in the UK, depending on the
estimation method chosen [9]. In addition, the costs as-
sociated with the health problems experienced by the in-
fant during the first year following the birth were found
to be between £12 and £23 million [9]. Smoking during
pregnancy poses a considerable economic burden in the
USA as well, since smoking-attributable neo-natal costs
were estimated to be nearly $228 million in total [10].
When long-term impacts on the infant are considered,
the actual figures are likely to be higher. Therefore, to
have a comprehensive estimate of the health and cost
impacts of SDP to inform policy decisions and ensure
that scarce health resources are allocated optimally, it is
necessary to review the evidence on the overall health ef-
fects for mothers and infants over the longer term.
A scoping review and a review of reviews by Godfrey
and colleagues [9], and a scoping review by Jones [11]
provided a picture of the health and cost outcomes asso-
ciated with SDP, and several narrative reviews about the
health outcomes have been published [12–15]. However,
none of these papers were fully systematic and compre-
hensive. Moreover, a considerable number of systematic
reviews have been published more recently on the im-
pact of maternal SDP on separate health outcomes,
which makes this overall review of the current evidence
timely.
The present study aimed to investigate the overall
health impacts of maternal smoking during pregnancy
and the postpartum period on mothers and infants.
Additionally, the evidence on the impact of the number
cigarettes consumed and second-hand smoking (SHS) by
partner during pregnancy was assessed [16, 17].
Methods
The guideline provided by the Cochrane Handbook for
Systematic Reviews of Interventions [18] was followed.
The review was carried out according to a protocol
which included a detailed description of the method-
ology [19]. Umbrella reviews have been increasingly used
to summarise the existing evidence on an issue by ana-
lysing all systematic reviews conducted [18, 20]. Consid-
ering the large number of original studies about health
outcomes of SDP, an umbrella review was the appropri-
ate design for this research.
Searches were undertaken of CINAHL, EMBASE,
MEDLINE, PsycINFO, Web of Science, CRD Database
(includes DARE, NHSEED and HTA) and HMIC data-
bases. The search strategy for MEDLINE is presented in
the Additional file 1. All systematic reviews published in
English and by December 2017. Two independent re-
viewers conducted the study selection and quality assess-
ment. The data extraction toll is provided in the
Additional file 1: Table S1. The quality of included stud-
ies was assessed with a tool developed from the Centre
for Reviews and Dissemination (CRD) checklist, which
covers a range of issues including prior protocol use,
bias in study selection, and consideration of publication
bias and inclusion of a quality assessment [21]. Main
outcome measures were odds ratios and relative risks for
smoking women and their children compared to non-
smoking women and their children.
To evaluate the causal link between SDP and the iden-
tified conditions which were found to have an associ-
ation with SDP, a causal link analysis was conducted
using established methods [11]. The evidence on the
identified conditions was assessed and categorised using
the following criteria:
 Strong evidence - one systematic review with ≥8
studies (group 1) or more than one systematic
review (group 2);
 Weak evidence – more than one systematic review
reported conflicting findings (group 3) or one
systematic review reported limited number of
studies (< 8) which found a relationship (group 4).
A validity assessment was conducted by reducing the
threshold of eight studies to seven, and increasing it to
10 and 12. As discussed by Jones [11], this strength of
evidence analysis fulfilled five of the nine items proposed
by Hill [22] as conditions of a causal link (strength,
consistency, specificity, temporality, and plausibility). In
addition, the dose-response association was also consid-
ered. The remaining requirements (coherence, experi-
ment, and analogy) of the Hill [22] criteria were
irrelevant to this review as laboratory studies were not
included and no causes other than smoking of the iden-
tified conditions were considered.
Results
The database search yielded 744 studies and an add-
itional five studies were found through hand searching
the references of included studies. Following the removal
of duplicates and abstract screening, 64 studies were se-
lected for full-text analysis Fig. 1.
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Characteristics of the included studies
Most reviews (n = 46) were published since 2010. Only
13 reviews investigated a health condition related to
mothers; the other 49 reviews analysed infant-related
conditions, except two [23, 24] which evaluated the im-
pacts on both. Key characteristics of the included re-
views are provided in Additional file 1: Table S2.
In most reviews (n = 27 reviews), the included studies
were predominantly from HICs, and 22 of the included
reviews covered studies from HIC only. In two reviews
[3, 25] most of the included studies were concerned with
upper-middle-income countries.
In 12 reviews, the country of focus of the included
studies was not provided. However, one of them [26]
conducted a meta-analysis of the studies from Europe
only, and in five reviews, the language of the included
studies was either only English [27–29] or languages [30,
31] which are only spoken by HICs. In the remaining six
reviews [32–36] there was no indication of whether the
studies focussed on LMICs or HICs. Nevertheless, when
interpreting the results of these reviews, the possibility
that studies which were conducted in LMICs have been
included in addition to HICs should be born in mind.
Quality of the included studies
The quality scores of the reviews are provided in Add-
itional file 1: Table S2. The highest achievable score was
16, and most reviews (n = 46) scored between nine and
14 while two reviews [25, 32] achieved very low scores
of 4 and 5. Therefore, most of the included reviews were
moderate or high quality studies according to the criteria
used.
Study selection was made by two reviewers independ-
ently in almost half of the reviews (n = 31) to minimise
bias. The majority of the studies (n = 50) assessed publi-
cation bias. Heterogeneity was measured in all reviews
although causes of heterogeneity were not analysed in
some (n = 17). However, only seven reviews reported
protocol publication [3, 26, 33, 37–40].
Impacts of smoking during pregnancy on mothers
Overall, of the 14 reviews that reported the impact of
smoking on mothers, all except two [41, 42] conducted
meta-analyses (Additional file 1: Table S3). The reviews
presented consistent findings, suggesting a significantly
increased risk associated with smoking and seven health
conditions. The highest risks were reported for spontan-
eous miscarriage in assisted reproduction (OR = 2.65,
95% CI, 1.33–5.30, 28) and ectopic pregnancy (OR =
2.30, 95% CI, 2.02–2.80, 30). Two conditions (pre-
eclampsia and hypremesis gravidarum) were found to be
negatively associated with SDP. Hence, women who
smoked whilst pregnant were less likely to experience
these two conditions.
Impacts of smoking during pregnancy on infants
Studies found a smoking-related increased risk for 20
conditions and the highest impact was observed for sud-
den infant death syndrome (SIDS) (OR = 2.98, 95% CI,
2.51–3.54) [24], asthma (OR = 1.85, 95% CI, 1.35–2.53)
[1], LBW (OR = 1.75, 95% CI, 1.42–2.10), stillbirth (OR =
1.55, 95% CI, 1.36–1.78) [38] and obesity (OR = 1.60,
95% CI 1.37–1.88) [43]. Studies did not find any signifi-
cant association between 15 conditions and SDP,
Fig. 1 PRISMA Diagram for Study Selection
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including autism, brain tumors, breast cancer in daugh-
ters and testicular cancer in sons. On the other hand, a
protective impact on skin defects was observed in one
review [44].
Most studies (n = 42) investigating the impacts of SDP
on infants conducted a meta-analysis (Additional file 1:
Table S4), and only nine did not include this (Additional
file 1: Table S5). In these studies, there was no signifi-
cant relationship between maternal SDP and lung func-
tions, or Tourette’s syndrome.
The age group of study participants varied between
studies; for example, some conditions were assessed
amongst infants while some were measured in adults. In
some reviews, participants were both infants and adults.
Table 1 lists health conditions by the life stage they were
assessed.
The reviews included in this study indicated that ma-
ternal smoking increased the risk of death for the child
during the prenatal period, neonatal period and infancy.
The evidence showed maternal SDP did not only have
short-term impact but also some long-term outcomes
which could be detrimental for offspring. Moreover,
some of the conditions measured in early life stages
could continue later in life. For instance, some birth de-
fects and intellectual disability would affect later stages
of life.
Dose-response association
To understand the impact of reductions in smoking, the
relationship between the number of cigarettes consumed
and the health implications for infants or mothers were
investigated. Although a dose-response impact of SDP
was reported in 27 reviews (22 related to infant condi-
tions), it was statistically tested in just 17 studies.
Among them, four found no significant impact of SDP
and their dose-response tests showed similar results. In
addition, one review [62] reported a dose-response asso-
ciation for SIDS but did not provide the odds ratios.
Findings of the remaining 12 studies are summarised in
the Additional file 1: Table S6.
To define light, moderate and heavy smokers, most
studies [38, 39, 46, 62–64] chose smoking 10 cigarettes
daily as a cut-off point to distinguish light smokers from
moderate and heavy smokers. In some studies [4, 39, 46,
61, 64], both 10 cigarettes daily and 20 cigarettes daily
were utilised as the thresholds. In one review the num-
ber of cigarettes consumed daily for each category was
inconsistent [65]. All studies estimated the risk ratios
compared to non-smokers [66], except for one review, in
which light smokers were compared to moderate
smokers.
Included reviews showed that the risk of stillbirth,
birth defects, preterm birth and perinatal death ele-
vated as the number of cigarettes increased [4, 38, 39,
46]. In contrast, smoking not only protected against
pre-eclampsia but the risk reduced as exposure in-
creased [67].
A dose-response relationship was found in five reviews
although a pooled estimation was not calculated. They
reported an increased risk for placental abruption [68],
and for the offspring the risk of being overweight [57],
having oral clefts [29, 50], or a decrease in cognitive abil-
ities [53] increased along with the number of cigarettes
that the mothers consumed. Five reviews included stud-
ies reporting a dose-response relationship along with
others that did not find any relationship [1, 41, 51, 56,
69]. Therefore, it was not clear whether or not the risk
for some conditions (pre-eclampsia, and in the offspring
asthma, attention deficit hyperactivity disorder, and vi-
sion difficulties) was affected by the number of cigarettes
consumed.
Six reviews observed no significant association be-
tween the number of cigarettes consumed and the risk
of health conditions for the children exposed to mater-
nal SDP, although overall they reported a significantly
increased risk. These studies covered congenital heart
diseases [65], central nervous system tumors [64], child-
hood neuroblastoma [63], lower respiratory infections
(LRI) [37] and lymphoblastic leukaemia [66], and re-
duced menarche age in daughters [61].
Table 1 Health impacts of maternal SDP on infants by life stages
Life Stage Health outcomes
Perinatal Foetal loss in assisted reproduction, stillbirth, perinatal death, preterm birth [4, 38, 45, 46]
Neonatal Accelerated growth, birth defects (i.e. heart defects, oral clefts), LBW, neonatal death, neural tube defects, sleep apnoea [3, 23, 24, 39,
44, 46–51]
Infancy Asthma, cognitive parameters impairment (decreased IQ, impaired neurodevelopment), intellectual disability, lower respiratory illness
(LRI), SIDS, wheezing [1, 37, 42, 52–54]
Childhood ADHD, accelerated growth, asthma, central nervous system tumours, cognitive parameters impairment (decreased IQ), disruptive
behaviour disorders, intellectual disability, neuroblastoma, non-Hodgkin lymphoma, overweight, obesity, vision difficulties, wheezing
[1, 23, 27, 43, 52–60]
Adolescence Asthma, Central nervous system tumours, cognitive impairment (decreased IQ, poor school performance), neuroblastoma, overweight,
obesity, reduced menarche age in daughters, wheezing [1, 43, 53, 54, 57, 61]
Adulthood Central nervous system tumours, cognitive parameters impairment (decreased IQ), overweight, obesity [44, 54, 56, 58]
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Impacts of postnatal maternal smoking on infants
The main findings of the reviews which investigated the
impact of postnatal smoking on the infants are shown in
Additional file 1: Table S7. The reviews showed an in-
creased impact on asthma, LRI, SIDS and wheezing but
not on leukaemia and obesity. However, in some studies,
it was not clear whether or not the mothers included in
the studies smoked during the whole pregnancy as well
as the postpartum period. This is a significant consider-
ation as one study reported by Oken et al. [57] found no
increase in the prevalence of obesity when the mother
smoked only after birth, whereas smoking before and
throughout pregnancy were found to be related with an
increased risk [70].
Impact of second-hand smoking by partners
In addition to active smoking, SHS during pregnancy
could have health implications. It was important to
understand whether the health-related risks were higher
when partners smoked during pregnancy. Therefore,
partner-related findings of the included reviews were
analysed. Partner smoking was considered in only 12 re-
views of which six did not assess the impact of SHS spe-
cific to the pregnancy period (Additional file 1: Table
S8). None of the studies reported the combined impact
of SDP and SHS by the partner during pregnancy. Two
reviews reported an increased risk of SIDS [71] and
delay in mental development [25] when the partners of
non-smoking women smoked during pregnancy, while
no association was found for brain tumors [72] or breast
cancer risk in daughters [73].
Sub-group analyses in the included reviews
The reviews conducted sub-group analyses to assess the
impact of study design, sample size, the duration of the
infant exposure to smoking (i.e. pre-pregnancy, first tri-
mester or the whole pregnancy) and adjustments for
confounding factors. The study findings did not differ
significantly in most of the analyses except for adjust-
ments for confounding and study quality. The evidence
was not sufficient to make a comparison based on coun-
try income groups because most studies were from high-
income countries.
Although the included meta-analyses utilised the most
adjusted estimations of observational studies when pool-
ing their results, only 10 of the included reviews pro-
vided risk ratios for adjusted and unadjusted estimations
(Additional file 1: Table S9). Studies with unadjusted ra-
tios estimated greater values for miscarriage, perinatal
death, SDIS, overweight and obesity.
Sub-group analyses based on quality appraisal of the
included studies were conducted in 14 reviews (Add-
itional file 1: Table S10). The results showed that high-
quality studies reported higher ratios for some condi-
tions (overweight, obesity, placenta previa) as opposed to
lower or insignificant ratios for some others (e.g. LBW,
miscarriage, stillbirth).
Two reviews [46, 74] compared the type of smoking
status data and found similar results for biochemical and
self-reported data. The exposure period was researched
in five reviews [40, 41, 46, 64, 75], and the results
showed no significant difference between women who
quit early in pregnancy and those who did not smoke.
Causal link analysis
The causal link analysis identified a range of health con-
ditions found to have strong association with SDP; these
are presented in Table 2, grouped according to the
strength of evidence.
Nearly all of the conditions for which a strong associ-
ation was identified fulfilled the criteria for a causal link.
The health conditions were largely reported by moder-
ate- or high-quality reviews and there were consistent
findings in the sub-group analyses. There was not a suf-
ficient biological explanation to the correlation found
between hyperemesis gravidarum and SDP, hence al-
though there was a strong association, a causal link
could not be confirmed.
Discussion
This study analysed the health impacts of smoking dur-
ing pregnancy and during the postpartum period on
mothers and infants. The 64 included reviews covered
1744 studies relating to SDP or smoking during the
postpartum period. The review found that maternal SDP
has short-term and long-term health consequences, sug-
gesting a positive association between 20 infant-related
Table 2 Strength of evidence analysis
Groups Health conditions
Strong evidence (group 1) Miscarriage, hyperemesis gravidarum, LRI, neonatal death, and preterm birth, reduced live birth in assisted reproduction
Strong evidence (group 2) Abruptio placenta, ectopic pregnancy, placenta previa, pre-eclampsia,birth defects (except skin defect), asthma, LBW,
overweight, obesity, SIDS, stillbirth.
Weak evidence (group 3) Leukaemia, lymphoma, vision difficulties
Weak evidence (group 4) Cognitive parameters of children and young adults, disruptive behaviour disorders, intellectual disability, neuroblastoma,
preterm premature rupture of the membranes (PPROM), reduced menarche age, sleep apnea, skin defects, Tourette’s
syndrome.
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and seven mother-related conditions, and a negative as-
sociation with two maternal conditions. The review did
not find a statistically significant impact of SDP on 15
infant-related conditions while conflicting findings were
reported for leukaemia and lymphoma.
The causal link analysis of the conditions that were
found to have an association with SDP suggested that
five mother-related and 10 infant-related conditions had
a causal link with SDP. PPROM and intellectual disabil-
ity in children did not fulfil the criteria for the casual
link although meta-analyses reported a statistically sig-
nificant relationship with SDP.
Health conditions with conflicting results
Some health conditions were assessed in multiple meta-
analyses and they reported conflicting results. For in-
stance, the increased risk of having any type of birth de-
fect was statistically significant despite being small in the
effect size (OR = 1.18, 95% CI, 1.14–1.22) in one review
[39] as opposed to a borderline ratio (OR = 1.01, 95% CI,
0.96–1.07) reported in another [44]. The main difference
was the reduced risk of skin defects (OR = 0.82, 95% CI,
0.75–0.89) which was included in the latter [44] while
omitted in the former [39] without any justification. All
five studies included in this meta-analysis reported a
negative relationship and the heterogeneity was low
(P = 0.00001, I2 = 0%). Therefore, the evidence suggested
an increased risk of birth defects except for skin defects
amongst SDP exposed children. However, there was no
biological explanation for the potential protective impact
of SDP on skin defects.
Another health condition with mixed findings was leu-
kaemia. One meta-analysis [64] including 19 studies indi-
cated an insignificant decreased risk (OR = 0.99, 95% CI,
0.92–1.06) whereas another review [66] of 21 studies found
an increased risk (OR = 1.10, 95% CI, 1.02–1.19). The dif-
ference could be explained by the different studies included,
since there were only five studies common to both, and the
association between SDP and leukaemia is unclear.
Similarly, the reviews reported different results for
lymphoma. One meta-analysis [55] found an insignifi-
cant association between any lymphoma and SDP based
on eight studies (OR = 1.10, 95% CI, 0.96–1.27), al-
though positive relationship for non-Hodgkin lymphoma
was reported (OR = 1.22, 95% CI, 1.03–1.45, n = 8). An-
other review [64] which included six studies found an
increased risk for any lymphoma (OR = 1.21, 95% CI,
1.05–1.34). Hence, SDP increases the risk of non-
Hodgkin lymphoma but for other types of lymphoma
the impact is unclear.
Strengths and limitations of the umbrella review
To the best of the authors’ knowledge, this is the first
umbrella review on the topic and provides the most
systematic and comprehensive assessment of the current
evidence. The criteria to assess any causal links are an
important consideration. The tool developed by Hill [22]
is widely recognised for assessing causation. In addition
to these criteria, this study considered the quality of re-
views and the findings of sub-group analyses. Hence, the
conditions identified by the causal link analysis are very
likely to have a causal link with SDP.
The review has some limitations. Firstly, although sys-
tematic reviews are accepted as the highest in the evi-
dence hierarchy [76, 77], the focus on systematic reviews
alone meant some health conditions were not covered.
Some original studies have indicated the impact of SDP
on other infant-related conditions, such as diabetes [78],
hypomania [79], otitis [80] and pervasive development
disorder [81], which were not assessed in a systematic
review, and as a result were not included in this study.
Furthermore, SDP has been shown to be related to the
smoking uptake of the offspring [82, 83]. There are also
some maternal health conditions found to be related to
smoking whilst pregnant in one study; vein thrombosis,
myocardial infarction, influenza or pneumonia, bron-
chitis, gastrointestinal ulcers [84]. However, the current
study focused on the conditions for which there was
strong evidence from systematic reviews.
The methodological limitations of the original studies
covered in the included reviews should be born in mind
when interpreting the results of the current review. First,
long-term implications of SDP were often tested retro-
spectively by asking mothers whether or not they had
smoked during pregnancy. This clearly has limitations as
these studies were not designed to compare the offspring
of smoking mothers with the children of non-smoking
mothers to determine differences in their health, but ra-
ther to compare the exposure in children with particular
conditions and those without these conditions. The sec-
ond issue is the usual reliance on mother’s memory and
openness about their smoking behaviour is unsatisfac-
tory. The third issue is the impact of confounding fac-
tors. For example, a seven-year-old child with diagnosed
asthma could have a mother who smoked during preg-
nancy only and a father who smoked during pregnancy
and the postpartum period. To minimise the impact of
this the most adjusted estimations were reported in this
review.
The review in the context of literature
Two previous scoping reviews were conducted to define
the health outcomes of SDP although they did not focus
on systematic reviews [9, 11]. The scoping review by Jones
et al. [11] was more comprehensive and included 32
health conditions. A quality assessment was not con-
ducted but specific criteria were used to assess the
strength of the evidence. According to the criteria, Jones
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et al. suggested that the evidence for a link between obes-
ity and SDP was not strong [11]. However, the current
analysis suggests a causal link due to the inclusion of two
subsequently published systematic reviews [32, 43].
Some of the health conditions covered in this study
were also included in the review by Godfrey et al. but
often higher ratios were reported [9]. This might be be-
cause they included narrative reviews which did not sep-
arate maternal SDP and postnatal passive smoke
exposure while estimating the summary risk ratios [24,
85–87]. Moreover, none of the previous reviews analysed
the impact of the number of cigarettes consumed, part-
ners’ smoking and postpartum smoking on infants.
Therefore, the current review is more comprehensive
and more systematic than previous studies.
Gaps in the literature
The study identified important gaps in the literature
which warrant further research. In particular, there is a
need to further our understanding of dose-response as-
sociation, the impact of postnatal smoking, and SHS
during pregnancy. Current evidence on the impact of
number of cigarettes consumed suggests that even low
amounts of cigarette consumption during pregnancy
have significant health outcomes and there is a clear gra-
dient for some conditions. This indicates the importance
of smoking cessation during pregnancy and if reduction
in smoking which is often not addressed in smoking ces-
sation interventions designed for pregnant women.
Only two studies assessed the impact of SHS by part-
ners during pregnancy when the mother was a non-
smoker. There was no review reporting the combined
impact of SDP and SHS by partners during pregnancy
while two reviews reported increased risks for
SID [43] and delay in mental development [25] when
only the partner smoked during pregnancy. Hence, more
research is needed to understand the impacts of having
a smoking partner during pregnancy.
Conclusion
This study has shown that smoking during pregnancy
and the postpartum period has significant health conse-
quences for mothers and infants. It is important to en-
courage pregnant smokers to quit smoking or reduce
the number of cigarettes consumed if they are not pre-
pared to quit entirely since the existing evidence indi-
cates a dose-response association. Similarly, the impact
of SHS needs to be considered to promote a smoke-free
environment for the mother and infant.
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